Richard Broughton

Title: The Innovative Contributions of Richard Broughton

Introduction

Richard Broughton is a notable inventor based in Montreal, Canada. He has made significant contributions to the field of biomedical research, particularly in the area of wound healing processes. His innovative work has led to the development of a patent that addresses critical aspects of cell proliferation and tissue regeneration.

Latest Patents

Richard Broughton holds a patent titled "Attenuation of wound healing processes." This patent focuses on the use of glycosaminoglycans, including heparinases 1, 2, and 3, as well as chondroitinases AC and B from the Gram-negative bacteria Flavobacterium heparinum. The invention describes how these enzymes can be utilized separately or in combination to manipulate cell proliferation. By administering heparinases to degrade heparan sulfate components of the extracellular matrix, the mobility of chemoattractant agents and growth factors can be enhanced, facilitating better healing processes.

Career Highlights

Broughton is associated with Ibex Technologies R and D, Inc., where he continues to advance his research in the field. His work has been instrumental in understanding how enzymatic removal of chondroitin sulfates from cell surfaces can increase the availability of growth factor receptors. This innovative approach has the potential to significantly impact therapeutic strategies for wound healing.

Collaborations

Richard Broughton has collaborated with esteemed colleagues such as Joseph J Zimmermann and Israel Vlodavsky. These partnerships have further enriched his research and contributed to the advancement of knowledge in the field of biomedical sciences.

Conclusion

Richard Broughton's innovative contributions to wound healing processes through his patented research exemplify the importance of scientific inquiry in improving health outcomes. His work continues to inspire advancements in biomedical research and therapeutic applications.